查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825955

2025年德国麻疹诊断检测全球市场报告

Rubella Diagnostic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，德国德国麻疹诊断检测市场规模强劲成长，从2024年的13亿美元增加至2025年的13.9亿美元，复合年增长率为6.7%。这段时期的成长归因于疫苗接种计划的推广、疫苗可预防疫情的发病率上升、政府控制德国麻疹病毒的倡议以及非传统环境下诊断检测的扩展。

预计未来几年德国麻疹诊断检测市场规模将强劲成长，到2029年将达到17.8亿美元，复合年增长率为6.5%。预测期内的成长可归因于医疗保健支出的增加、对预防保健的重视程度的提高、人们对疫苗可预防疾病的认识的提高、公共卫生宣传活动的扩大以及远距远端医疗和远距离诊断的扩展。预测期内的主要趋势包括诊断技术的进步、医疗保健系统中的技术整合、就地检验解决方案的开发、新型诊断方法的开发以及分子诊断技术的进步。

德国麻疹诊断检测包括用于检测患者血液中是否有德国麻疹病毒或抗体的方法，并确定患者是否感染风疹或对德国麻疹具有免疫力。这些检测使医疗保健提供者能够准确诊断德国麻疹并控制其影响，尤其是在脆弱人群中。

德国麻疹检测的主要诊断技术包括乳胶凝集测试、肝功能检查、酵素免疫分析法试验 (EIA)、免疫检测(RIA) 和萤光免疫分析(FIA)。乳胶凝集测试是一种诊断方法，将涂有德国麻疹特异性抗原或抗体的乳胶小珠与患者检体混合。此方法适用于新生儿、青少年和成人等不同年龄层，并服务于包括医院、诊所、癌症诊断中心和门诊手术中心在内的广泛终端使用者。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供德国麻疹诊断检测市场统计数据，例如德国麻疹德国麻疹诊断检测行业市场规模、区域份额、竞争对手的市场份额、详细的德国麻疹诊断检测细分市场、市场趋势和商机，以及您在德国麻疹诊断检测行业取得成功所需的数据。本德国麻疹诊断检测市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年6.5%的成长率预测较先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致韩国和法国开发的检测套组价格上涨，阻碍德国麻疹快速IgM检测法在美国的广泛应用。互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响可能会产生更广泛的影响。

病毒感染疾病的日益普及预计将推动德国麻疹诊断检测市场的未来成长。病毒感染疾病是由病毒引起的疾病，病毒是一种只能在宿主活细胞内复製的小型传染原。病毒感染疾病的增加是由于全球旅行的增加，这使得病毒能够跨境迅速传播，以及气候变化，这改变了媒介栖息地并扩大了携带疾病的生物体的分布。德国麻疹诊断检测对于德国麻疹感染的早期发现和管理、预防併发症（尤其是在孕妇中）以及促进疫情控制以最大限度地减少病毒传播至关重要。例如，2023 年 12 月，英国政府机构国家医疗服务体系 (NHS) 报告称，平均每天有 234 人因流感住院，比前一周增加了 53%。此外，住院的诺罗病毒患者人数增加了 15%，平均每天达到 406 人，与去年同期相比增加了 28%。因此，病毒感染病例的增加正在推动德国麻疹诊断检测市场的成长。

德国麻疹诊断检测市场的主要企业正致力于开发创新解决方案，例如德国麻疹病毒疫苗，以提高诊断准确性并加强预防措施。德国麻疹病毒疫苗可提供针对德国麻疹的免疫力，通常包含在 MMR 和 MMRV 联合疫苗中，以预防该疾病及其併发症。例如，2023 年 3 月，美国製药公司默克公司获得 FDA核准，可以肌肉注射 (IM) 其 MMR II 疫苗，这不仅对于预防德国德国麻疹，而且对于预防麻疹和流行性腮腺炎都至关重要。这项核准允许医疗保健提供者透过 IM 途径施用德国麻疹疫苗，将其与其他常规建议的儿科疫苗一起施用。接种德国麻疹疫苗对于预防疫情和保护孕妇德国麻疹病毒引起的潜在严重併发症至关重要。

2024年9月，美国高纯度抗体开发公司Leinco Technologies Inc.收购了QED Biosciences，收购金额未揭露。此次收购旨在扩大Leinco Technologies的抗体产品系列和开发服务，增强其在生命科学和体外诊断领域的能力，并支持公司的成长策略以及为全球研究人员提供创新和品质的承诺。 QED Biosciences专注于开发新型单株和多多株抗体产品，并提供德国麻疹诊断检测服务。

德国麻疹诊断检测市场由提供血清学检测服务、血清学测试、分子诊断服务和快速诊断检测服务等服务的营业单位所获得的收益所构成。市场规模包括服务提供者销售的或包含在其服务产品中的任何相关产品的价值。德国麻疹诊断检测市场还包括血清学检测、IgM 抗体、快速诊断检测 (RDT) 和聚合酵素链锁反应(PCR) 检测的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球德国麻疹诊断测试：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球德国麻疹诊断测试市场：成长率分析
  • 全球德国麻疹诊断检测市场表现：规模与成长，2019-2024
  • 全球德国麻疹诊断检测市场预测：2024-2029年、2034年规模与成长
  • 全球德国麻疹诊断检验：总目标市场（TAM）

第六章 市场细分

  • 全球德国麻疹诊断检测市场（依诊断技术、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 乳胶凝集测试
  • 肝功能检查
  • 酵素免疫分析法（EIA）
  • 免疫检测（RIA）
  • 萤光免疫分析（FIA）
  • 其他的
  • 全球德国麻疹诊断检测市场（依年龄层、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 新生
  • 青年
  • 成人
  • 全球德国麻疹诊断检测市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 癌症诊断中心
  • 门诊手术中心
  • 其他的
  • 全球德国麻疹诊断测试市场：乳胶凝集测试细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 定性乳胶凝集试验
  • 定量乳胶凝集试验
  • 快速乳胶凝集试剂套件
  • 全球德国麻疹诊断检测市场：肝功能检测细分、类型、表现及预测（2019-2024、2024-2029、2034）
  • 血清胆红素检测
  • 丙胺基转移酶（ALT）检测
  • 天门冬胺基转移酶（AST）检测
  • 碱性磷酸酶（ALP）检测
  • 其他的
  • 全球德国麻疹诊断检测市场：酵素免疫分析法（EIA）细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接环境影响评估
  • 间接环境影响评价
  • 三明治环境影响评估
  • 竞争性环境影响评估
  • 全球德国麻疹诊断检测市场：免疫检测（RIA）细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准 RIA
  • 改良放射免疫分析法
  • 单抗体放射免疫分析
  • 全球德国麻疹诊断检测市场：萤光免疫分析（FIA）细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接 FIA
  • 间接金融影响评估
  • 三明治 FIA
  • 全球德国麻疹诊断检测市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 核酸增幅检查（NAAT）
  • 基于微孔盘的检测
  • 西方印渍术

第七章 区域和国家分析

  • 全球德国麻疹诊断检测市场各地区、绩效及预测（2019-2024、2024-2029、2034）
  • 全球德国麻疹诊断检测市场（按国家/地区、绩效和预测），2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 德国麻疹诊断检测市场：竞争格局
  • 德国麻疹诊断检测市场：公司简介
    • Cardinal Health Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd

第31章：其他领先和创新企业

  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Ortho-Clinical Diagnostics Inc.
  • DiaSorin SpA
  • Meridian Bioscience Inc.
  • Fortress Diagnostics Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • MP Biomedicals LLC
  • CTK BIoTech Inc.
  • ZEUS Scientific Inc.
  • Creative Diagnostics
  • Arlington Scientific Inc.
  • AccuBioTech Co. Ltd.
  • Intec Products Inc.
  • Vitrosens BIoTechnology Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年德国麻疹诊断检测市场：提供新机会的国家
  • 2029 年德国麻疹诊断检测市场：细分领域带来新机会
  • 2029年德国麻疹诊断检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32213u

Rubella diagnostic testing involves methods used to detect the presence of the rubella virus or antibodies in a patient's blood, confirming whether they have been infected with rubella or possess immunity against it. These tests enable healthcare providers to accurately diagnose rubella and manage its implications, particularly for vulnerable populations.

The primary types of diagnostic techniques used in rubella testing include latex agglutination, liver function tests, enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescent immunoassay (FIA), and others. Latex agglutination is a diagnostic approach where small latex beads coated with rubella-specific antigens or antibodies are mixed with a patient's sample. This technique can be applied across various age groups, including neonates, teenagers, and adults, serving a wide range of end users such as hospitals, clinics, cancer diagnostic centers, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The rubella diagnostic testing market research report is one of a series of new reports from The Business Research Company that provides rubella diagnostic testing market statistics, including rubella diagnostic testing industry global market size, regional shares, competitors with a rubella diagnostic testing market share, detailed rubella diagnostic testing market segments, market trends and opportunities, and any further data you may need to thrive in the rubella diagnostic testing industry. This rubella diagnostic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rubella diagnostic testing market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to a rise in vaccination programs, a rising incidence of immunization-preventable outbreaks, government initiatives to combat the rubella virus, and the expansion of diagnostic testing in non-traditional settings.

The rubella diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing healthcare expenditure, growing focus on preventive healthcare, rising awareness of vaccine-preventable diseases, growing public health campaigns, and expansion of telemedicine and remote diagnostics. Major trends in the forecast period include advancements in diagnostic technologies, technological integration in healthcare systems, development of point-of-care testing solutions, development of new diagnostic methods, and advancements in molecular diagnostics.

The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of rapid rubella IgM assays by inflating prices of test kits developed in South Korea and France, resulting in delayed outbreak containment and higher public health costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of viral infections is anticipated to drive the growth of the rubella diagnostic testing market in the future. Viral infections are illnesses caused by viruses, which are tiny infectious agents that can only replicate within the living cells of a host organism. The rise in viral infections can be attributed to heightened global travel, which allows for the rapid spread of viruses across borders, as well as climate change, which modifies vector habitats and expands the distribution of disease-carrying organisms. Rubella diagnostic testing is crucial for early identification and management of rubella infections, helping to prevent complications, especially in pregnant women, and facilitating outbreak control to minimize virus transmission. For instance, in December 2023, the National Health Service, a UK government department, reported an average of 234 daily hospital admissions for flu, representing a 53% increase from the previous week. Additionally, hospital cases of norovirus rose by 15%, averaging 406 daily, which is a 28% increase compared to the same week last year. Consequently, the increasing cases of viral infections are propelling the growth of the rubella diagnostic testing market.

Key companies in the rubella diagnostic testing market are concentrating on developing innovative solutions, such as rubella virus vaccines, to improve diagnostic accuracy and enhance preventive measures. The rubella virus vaccine provides immunity against rubella and is often included in the MMR or MMRV combination vaccines to prevent the disease and its complications. For example, in March 2023, Merck & Co., Inc., a U.S.-based pharmaceutical company, received FDA approval for the intramuscular (IM) administration of its M-M-R II vaccine, which is essential for protecting against rubella, as well as measles and mumps. This approval enables healthcare providers to administer the rubella vaccine via the IM route, aligning it with other routinely recommended pediatric vaccines. Vaccination against rubella is critical for preventing outbreaks and safeguarding against the severe complications that the virus can inflict, particularly in pregnant women.

In September 2024, Leinco Technologies Inc., a U.S.-based developer of high-purity antibodies, acquired QED Biosciences for an undisclosed sum. This acquisition aims to expand Leinco Technologies' antibody product portfolio and development services, enhancing its capabilities in life sciences and in vitro diagnostics while supporting its growth strategy and commitment to innovation and quality for researchers worldwide. QED Biosciences specializes in developing novel monoclonal and polyclonal antibody products and offers rubella diagnostic testing services.

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

North America was the largest region in the rubella diagnostic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rubella diagnostic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rubella diagnostic testing market consists of revenues earned by entities by providing services such as serological testing services, serologic tests, molecular diagnostic services, and rapid diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rubella diagnostic testing market also includes sales of serological assays, IgM antibodies, rapid diagnostic tests (RDTs), and polymerase chain reaction (PCR) tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rubella Diagnostic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rubella diagnostic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rubella diagnostic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rubella diagnostic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Technique: Latex Agglutination; Liver Function Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (Ria); Fluorescent Immunoassay (FIA); Other Diagnostic Techniques
  • 2) By Age Group: Neonates; Teenagers; Adults
  • 3) By End User: Hospitals And Clinics; Cancer Diagnostic Centers; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Latex Agglutination: Qualitative Latex Agglutination Tests; Quantitative Latex Agglutination Tests; Rapid Latex Agglutination Kits
  • 2) By Liver Function Tests: Serum Bilirubin Tests; Alanine Aminotransferase (ALT) Tests; Aspartate Aminotransferase (AST) Tests; Alkaline Phosphatase (ALP) Tests; Other Liver Enzyme Tests
  • 3) By Enzyme Immunoassay (EIA): Direct EIA; Indirect EIA; Sandwich EIA; Competitive EIA
  • 4) By Radioimmunoassay (RIA): Standard RIA; Modified RIA; Single-Antibody RIA
  • 5) By Fluorescent Immunoassay (FIA): Direct FIA; Indirect FIA; Sandwich FIA
  • 6) Other Diagnostic Techniques: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAAT); Microplate-Based Assays; Western Blotting
  • Companies Mentioned: Cardinal Health Inc.; Siemens Healthineers AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; bioMerieux S.A.; Bio-Rad Laboratories Inc.; Ortho-Clinical Diagnostics Inc.; DiaSorin S.p.A.; Meridian Bioscience Inc.; Fortress Diagnostics Ltd.; Mylab Discovery Solutions Pvt. Ltd.; MP Biomedicals LLC; CTK Biotech Inc.; ZEUS Scientific Inc.; Creative Diagnostics; Arlington Scientific Inc.; AccuBioTech Co. Ltd.; Intec Products Inc.; Vitrosens Biotechnology Ltd.; Sprint Diagnostics Pvt. Ltd.; InDevR Inc.; Atlas Medical GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rubella Diagnostic Testing Market Characteristics

3. Rubella Diagnostic Testing Market Trends And Strategies

4. Rubella Diagnostic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rubella Diagnostic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Rubella Diagnostic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Rubella Diagnostic Testing Market Growth Rate Analysis
  • 5.4. Global Rubella Diagnostic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Rubella Diagnostic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Rubella Diagnostic Testing Total Addressable Market (TAM)

6. Rubella Diagnostic Testing Market Segmentation

  • 6.1. Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Latex Agglutination
  • Liver Function Tests
  • Enzyme Immunoassay (EIA)
  • Radioimmunoassay (RIA)
  • Fluorescent Immunoassay (FIA)
  • Other Diagnostic Techniques
  • 6.2. Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neonates
  • Teenagers
  • Adults
  • 6.3. Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Cancer Diagnostic Centers
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.4. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Latex Agglutination, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Qualitative Latex Agglutination Tests
  • Quantitative Latex Agglutination Tests
  • Rapid Latex Agglutination Kits
  • 6.5. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Liver Function Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Bilirubin Tests
  • Alanine Aminotransferase (ALT) Tests
  • Aspartate Aminotransferase (AST) Tests
  • Alkaline Phosphatase (ALP) Tests
  • Other Liver Enzyme Tests
  • 6.6. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Enzyme Immunoassay (EIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct EIA
  • Indirect EIA
  • Sandwich EIA
  • Competitive EIA
  • 6.7. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Radioimmunoassay (RIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard RIA
  • Modified RIA
  • Single-Antibody RIA
  • 6.8. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Fluorescent Immunoassay (FIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct FIA
  • Indirect FIA
  • Sandwich FIA
  • 6.9. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Other Diagnostic Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification Tests (NAAT)
  • Microplate-Based Assays
  • Western Blotting

7. Rubella Diagnostic Testing Market Regional And Country Analysis

  • 7.1. Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rubella Diagnostic Testing Market

  • 8.1. Asia-Pacific Rubella Diagnostic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rubella Diagnostic Testing Market

  • 9.1. China Rubella Diagnostic Testing Market Overview
  • 9.2. China Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rubella Diagnostic Testing Market

  • 10.1. India Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rubella Diagnostic Testing Market

  • 11.1. Japan Rubella Diagnostic Testing Market Overview
  • 11.2. Japan Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rubella Diagnostic Testing Market

  • 12.1. Australia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rubella Diagnostic Testing Market

  • 13.1. Indonesia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rubella Diagnostic Testing Market

  • 14.1. South Korea Rubella Diagnostic Testing Market Overview
  • 14.2. South Korea Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rubella Diagnostic Testing Market

  • 15.1. Western Europe Rubella Diagnostic Testing Market Overview
  • 15.2. Western Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rubella Diagnostic Testing Market

  • 16.1. UK Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rubella Diagnostic Testing Market

  • 17.1. Germany Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rubella Diagnostic Testing Market

  • 18.1. France Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rubella Diagnostic Testing Market

  • 19.1. Italy Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rubella Diagnostic Testing Market

  • 20.1. Spain Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rubella Diagnostic Testing Market

  • 21.1. Eastern Europe Rubella Diagnostic Testing Market Overview
  • 21.2. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rubella Diagnostic Testing Market

  • 22.1. Russia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rubella Diagnostic Testing Market

  • 23.1. North America Rubella Diagnostic Testing Market Overview
  • 23.2. North America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rubella Diagnostic Testing Market

  • 24.1. USA Rubella Diagnostic Testing Market Overview
  • 24.2. USA Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rubella Diagnostic Testing Market

  • 25.1. Canada Rubella Diagnostic Testing Market Overview
  • 25.2. Canada Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rubella Diagnostic Testing Market

  • 26.1. South America Rubella Diagnostic Testing Market Overview
  • 26.2. South America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rubella Diagnostic Testing Market

  • 27.1. Brazil Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rubella Diagnostic Testing Market

  • 28.1. Middle East Rubella Diagnostic Testing Market Overview
  • 28.2. Middle East Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rubella Diagnostic Testing Market

  • 29.1. Africa Rubella Diagnostic Testing Market Overview
  • 29.2. Africa Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rubella Diagnostic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Rubella Diagnostic Testing Market Competitive Landscape
  • 30.2. Rubella Diagnostic Testing Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Rubella Diagnostic Testing Market Other Major And Innovative Companies

  • 31.1. bioMerieux S.A.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Ortho-Clinical Diagnostics Inc.
  • 31.4. DiaSorin S.p.A.
  • 31.5. Meridian Bioscience Inc.
  • 31.6. Fortress Diagnostics Ltd.
  • 31.7. Mylab Discovery Solutions Pvt. Ltd.
  • 31.8. MP Biomedicals LLC
  • 31.9. CTK Biotech Inc.
  • 31.10. ZEUS Scientific Inc.
  • 31.11. Creative Diagnostics
  • 31.12. Arlington Scientific Inc.
  • 31.13. AccuBioTech Co. Ltd.
  • 31.14. Intec Products Inc.
  • 31.15. Vitrosens Biotechnology Ltd.

32. Global Rubella Diagnostic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rubella Diagnostic Testing Market

34. Recent Developments In The Rubella Diagnostic Testing Market

35. Rubella Diagnostic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Rubella Diagnostic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Rubella Diagnostic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Rubella Diagnostic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer